Autolus Therapeutics
AUTL
$4.39
Share price
7.86%
Change (1 day)
48.81%
Change (1 year)
Categories
Autolus Therapeutics (AUTL) - P/B ratio
P/B ratio as of May 2024 : 9.71
According to Autolus Therapeutics's latest financial reports the company has a price-to-book ratio of 9.71.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Autolus Therapeutics - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 10.0 | 811.41% |
| 2022-12-31 | 1.10 | -26.89% |
| 2021-12-31 | 1.51 | -32.42% |
| 2020-12-31 | 2.23 | -4.37% |
| 2019-12-31 | 2.33 | -58.88% |
| 2018-12-31 | 5.67 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -72.05% | 🇺🇸 USA |